Mirum Pharmaceuticals, Inc. (MIRM): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

50.20M
Year ended 2025-12-31
+13.9%
3-year compound annual growth
2021-12-31: 30.32M2022-12-31: 33.98M2023-12-31: 40.89M2024-12-31: 47.52M2025-12-31: 50.20M50.20M
2021-12-31 Weighted Average Diluted Shares (shares) 2025-12-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-3150.20M+5.6%2026-02-25, From 2025-01-01
2024-12-3147.52M+16.2%2026-02-25, From 2024-01-01
2023-12-3140.89M+20.3%2026-02-25, From 2023-01-01
2022-12-3133.98M+12.1%2025-02-26, From 2022-01-01
2021-12-3130.32Mn/a2024-03-15, From 2021-01-01